Related Tags >> Roche Rheumatoid Arthritis FDA Phase III

Actemra News

Most Popular Actemra Story

FDA delays Roche's blockbuster Actemra

September 19, 2008 — 10:20am ET | By John Carroll

The FDA is delaying approval of Roche's new rheumatoid arthritis drug Actemra, saying that it wants to... Read more...

Actemra Press Releases

FDA approves ACTEMRA for the treatment of moderately to severely active rheumatoid arthritis
Roche and FDA Agree on Pathway Towards U.S. Approval of Actemra (tocilizumab)
New data shows ACTEMRA inhibits progression of joint destruction and improves physical function of patients with Rheumatoid Arth
FDA issues complete response letter to Roche for Actemra Biologics License Application
FDA Issues Complete Response Letter to Roche for ACTEMRA(R) (tocilizumab) Biologics License Application

Latest Headlines

FDA approves Roche's Actemra for RA
January 11, 2010
Roche touts Actemra results for sJIA
November 20, 2009
EMEA approves sale of Roche's RA blockbuster
January 21, 2009
Roche hit with major delay on Actemra approval
December 4, 2008
Roche boasts new data supporting Actemra, MabThera
October 28, 2008
FDA delays Roche's blockbuster Actemra
September 19, 2008
Blockbuster RA drug wins FDA panel vote
July 30, 2008
FDA staffers say Actemra works against RA
July 28, 2008
Roche posts new data backing Actemra for RA
May 12, 2008
Roche seeks FDA approval of RA drug Actemra
November 21, 2007
Roche posts strong data from RA trials
November 8, 2007
Roche sees positive late-stage data on Actemra
June 14, 2007
SPOTLIGHT: New data on Actemra
May 13, 2007
SPOTLIGHT: Chugai seeks Actemra approval
April 27, 2006

Paid Research Reports

More Research Reports >>